GlucoTrack, Inc. (GCTK)
2.93
-0.05
(-1.68%)
USD |
NASDAQ |
Sep 08, 16:00
2.97
+0.04
(+1.37%)
Pre-Market: 09:15
GlucoTrack Shareholders Equity (Quarterly) : -1.741M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.741M |
| March 31, 2026 | -0.851M |
| December 31, 2025 | 2.828M |
| September 30, 2025 | 2.751M |
| June 30, 2025 | 6.88M |
| March 31, 2025 | 7.258M |
| December 31, 2024 | -13.00M |
| September 30, 2024 | -4.022M |
| June 30, 2024 | -3.289M |
| March 31, 2024 | 0.376M |
| December 31, 2023 | 3.197M |
| September 30, 2023 | 5.557M |
| June 30, 2023 | 7.743M |
| March 31, 2023 | 0.006M |
| December 31, 2022 | 1.226M |
| September 30, 2022 | 2.337M |
| June 30, 2022 | 3.181M |
| March 31, 2022 | 4.22M |
| December 31, 2021 | 5.155M |
| September 30, 2021 | 6.476M |
| June 30, 2021 | 7.276M |
| March 31, 2021 | 8.149M |
| December 31, 2020 | 8.982M |
| September 30, 2020 | 9.899M |
| June 30, 2020 | 10.36M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.88M |
| December 31, 2019 | -1.412M |
| September 30, 2019 | -0.8628M |
| June 30, 2019 | 0.0154M |
| March 31, 2019 | -2.686M |
| December 31, 2018 | -2.873M |
| September 30, 2018 | -2.575M |
| June 30, 2018 | -3.563M |
| March 31, 2018 | -2.865M |
| December 31, 2017 | -3.154M |
| September 30, 2017 | -1.422M |
| June 30, 2017 | -0.4856M |
| March 31, 2017 | -0.5937M |
| December 31, 2016 | -0.908M |
| September 30, 2016 | -0.1686M |
| June 30, 2016 | 0.531M |
| March 31, 2016 | -1.286M |
| December 31, 2015 | -0.0339M |
| September 30, 2015 | 1.463M |
| June 30, 2015 | 2.580M |
| March 31, 2015 | 3.115M |
| December 31, 2014 | 2.916M |
| September 30, 2014 | 1.670M |
| June 30, 2014 | -2.357M |
| March 31, 2014 | -7.515M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nuwellis, Inc. | -2.045M |
| Abbott Laboratories | 51.11B |
| DexCom, Inc. | 2.621B |
| Insulet Corp. | 1.422B |
| AngioDynamics, Inc. | 170.82M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.495M |
| Total Liabilities (Quarterly) | 3.236M |
| Debt to Equity Ratio | -1.125 |
| Current Ratio | 0.4622 |
| Net Debt Paydown Yield | -17.00% |